In this section, we are regularly sharing relevant information on patient-focused drug development.
Following the outbreak of the COVID-19 pandemic, we now see that investigator result meetings have changed their format to online interaction...Read More
When pharmaceutical companies have completed a clinical trial, they may want to organise a result meeting with the attendance of participating...Read More
When pharmaceutical companies develop new medicines, they are required to comply with regulatory requirements by reporting and publishing their clinical results. Adhering to these...Read More
The importance of keeping your trial patients well-informed. True patient-centricity is not only obtaining input from trial patients – it also involves ...Read More
Patient and Public Involvement (PPI) can improve clinical research success. PPI is defined as research that is carried out with or by patients and those who have experience of a condition...Read More
Are you overlooking patient feedback on your investigational drug? Interestingly, the pharmaceutical industry is one of the few industries where...Read More